These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31781610)

  • 21. Assessing Botulinum Toxin Effectiveness and Quality of Life in Axillary Hyperhidrosis: A One-Year Prospective Study.
    Castiglione L; Murariu M; Boeriu E; Enatescu I
    Diseases; 2024 Jan; 12(1):. PubMed ID: 38248366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of hyperhidrosis by a battery-operated iontophoretic device.
    Hölzle E; Ruzicka T
    Dermatologica; 1986; 172(1):41-7. PubMed ID: 3956820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality of life and social isolation in Greek adolescents with primary focal hyperhidrosis treated with botulinum toxin type A: a case series.
    Kouris A; Armyra K; Stefanaki C; Christodoulou C; Karimali P; Kontochristopoulos G
    Pediatr Dermatol; 2015; 32(2):226-30. PubMed ID: 25557249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative Study of Efficacy and Safety of Botulinum Toxin a Injections and Subcutaneous Curettage in the Treatment of Axillary Hyperhidrosis.
    Budamakuntla L; Loganathan E; George A; Revanth BN; Sankeerth V; Sarvjnamurthy SA
    J Cutan Aesthet Surg; 2017; 10(1):33-39. PubMed ID: 28529419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantification of sweat secretion in focal axillary hyperhidrosis related to area and time: the hyperhidrosis area and secretion index.
    Bahmer FA
    Int J Dermatol; 2015 Nov; 54(11):1233-5. PubMed ID: 26474188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A retrospective analysis of the use of tap water iontophoresis for focal hyperhidrosis at a district general hospital: the patients' perspective.
    Gollins CE; Carpenter A; Steen C; Bulinski H; Mahendran R
    J Dermatolog Treat; 2019 Nov; 30(7):724-726. PubMed ID: 30646797
    [No Abstract]   [Full Text] [Related]  

  • 27. Current treatments for axillary hyperhidrosis.
    Fitzgerald E; Feeley TM; Tierney S
    Surgeon; 2004 Dec; 2(6):311-4, 360. PubMed ID: 15712569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A survey of long-term results with microwave energy device for treating axillary hyperhidrosis.
    Lin MJ; Dubin DP; Genece J; Younessi S; Rai S; Khorasani H
    J Cosmet Laser Ther; 2021 May; 23(3-4):49-51. PubMed ID: 34409892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Durability of botulinum toxin treatment for axillary hyperhidrosis.
    Moffat CE; Hayes WG; Nyamekye IK
    Eur J Vasc Endovasc Surg; 2009 Aug; 38(2):188-91. PubMed ID: 19395290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pulsed direct current iontophoresis as a possible new treatment for hyperhidrosis].
    Reinauer S; Neusser A; Schauf G; Hölzle E
    Hautarzt; 1995 Aug; 46(8):543-7. PubMed ID: 7558823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxybutynin in primary hyperhidrosis: A long-term real-life study.
    Almeida ART; Ferrari F; Restrepo MVS; Rocha VB
    Dermatol Ther; 2020 Nov; 33(6):e14344. PubMed ID: 32981151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of iontophoresis with glycopyrronium bromide for treatment of primary palmar hyperhidrosis.
    Chia HY; Tan AS; Chong WS; Tey HL
    J Eur Acad Dermatol Venereol; 2012 Sep; 26(9):1167-70. PubMed ID: 21812834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety.
    Lowe NJ; Glaser DA; Eadie N; Daggett S; Kowalski JW; Lai PY;
    J Am Acad Dermatol; 2007 Apr; 56(4):604-11. PubMed ID: 17306417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic effectiveness of botulinum toxin type A based on severity of palmar hyperhidrosis.
    Ito K; Yanagishita T; Ohshima Y; Tamada Y; Watanabe D
    J Dermatol; 2011 Sep; 38(9):859-63. PubMed ID: 21545498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Translation and validation of Hyperhidrosis Disease Severity Scale.
    Varella AY; Fukuda JM; Teivelis MP; Campos JR; Kauffman P; Cucato GG; Puech-Leão P; Wolosker N
    Rev Assoc Med Bras (1992); 2016 Dec; 62(9):843-847. PubMed ID: 28001258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of focal idiopathic hyperhidrosis with Botulinum Toxin Type A: clinical predictive factors of relapse-free survival.
    Campanati A; Sandroni L; Gesuita R; Giuliano A; Giuliodori K; Marconi B; Ganzetti G; Offidani A
    J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):917-21. PubMed ID: 21054569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phase 2a randomized controlled study to evaluate the pharmacokinetic, safety, tolerability and clinical effect of topically applied Umeclidinium in subjects with primary axillary hyperhidrosis.
    Nasir A; Bissonnette R; Maari C; DuBois J; Pene Dumitrescu T; Haddad J; Yamaguchi Y; Dalessandro M
    J Eur Acad Dermatol Venereol; 2018 Jan; 32(1):145-151. PubMed ID: 29055158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iontophoresis with alternating current and direct current offset (AC/DC iontophoresis): a new approach for the treatment of hyperhidrosis.
    Reinauer S; Neusser A; Schauf G; Hölzle E
    Br J Dermatol; 1993 Aug; 129(2):166-9. PubMed ID: 7654577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of oral oxybutynin at 7.5 mg per day in primary hyperhidrosis].
    Try C; Messikh R; Elkhyat A; Aubin F; Humbert RP
    Rev Med Liege; 2012 Oct; 67(10):520-6. PubMed ID: 23167161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of intradermal injection with iontophoresis of abobotulinum toxin A for the treatment of primary axillary hyperhidrosis: a randomized, controlled trial.
    Montaser-Kouhsari L; Zartab H; Fanian F; Noorian N; Sadr B; Nassiri-Kashani M; Firooz A
    J Dermatolog Treat; 2014 Aug; 25(4):337-41. PubMed ID: 23106157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.